On April 9, 2024, the BIH Charité Advanced Clinician Scientist Pilot Program (AdCSP) was successfully evaluated by a top-class external panel of experts and can now enter the second funding phase of three years.
Charité/BIH and Enterprise Singapore (ESG) have established an innovation support program that promotes cooperation between excellent clinicians from Charité/BIH and start-ups from Singapore. Following the successful application of start-ups from Singapore, we are now looking for project partners at Charité/BIH.
On 28 February 2024, the team from Charité BIH Innovation (CBI) - the joint technology transfer of Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) - was delighted to receive a visit from Prof. Heyo. K. Kroemer, Chairman of the Executive Board of Charité, Prof. Dr Joachim Spranger, Dean of Charité, Prof. Dr Christopher…
Single-cell RNA sequencing (scRNA-seq) has expanded our ability to distinguish cell populations and elucidate their interactions with each other. However, there are still difficulties in distinguishing leukemia cells from normal hematopoiesis based on gene expression alone. Livius Penter, BIH Digital Clinician Scientist Fellow and specialist at the…
Charité/BIH spin-off TimeTeller GmbH has been named winner of the Health Innovation Award 2023.
On November 10, 2023 a significant milestone was reached when Charité - Universitätsmedizin Berlin, Berlin Institute of Health at Charité (BIH) and Enterprise Singapore signed a Memorandum of Understanding (MoU). This forms the basis for the upcoming launch of the Co-Innovation Program. This innovative program facilitates the professional…
The Berlin Institute of Health Center for Regenerative Therapies (BIH-CRT), Cluster Health Capital Berlin-Brandenburg, German Heart Center at Charité (DHZC) and Berlin Partner hosted the 10th RegMed Forum on November 23, 2023, at the Cranach Haus. The forum's primary objective was to engage various stakeholders in a meaningful dialogue about…
Again, this year the SPARK-BIH funding and mentoring program motivated many scientists and clinicians from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health at Charité (BIH) to submit their translational project proposals in the fields of pharma, diagnostics and medtech. The applicants presented their proposals to an expert…
Charité - Universitätsmedizin Berlin and the Israel Innovation Authority (IIA) launched a joint program in 2020 aimed at promoting and validating innovations in the field of digital medicine and medical technology. This collaborative project was relaunched in 2022 under the title "International Health-Tech R&D and Pilot Program". First and…
